Daniel Alfaiate | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-5581-4242

Daniel Alfaiate is a researcher affiliated with the Instituto Politécnico de Castelo Branco whose documented scholarly activity is situated within Medicine and Health Sciences. The available publication record includes research concerning sleep medicine, obstructive sleep apnea (OSA), electroencephalography, hematological outcomes, and psychotropic medication effects on sleep architecture. Bibliographic information identifies three Scopus documents and 31 citations, with a reported h-index of 2.

Abstract

The research profile of Daniel Alfaiate reflects an emerging focus on clinical and physiological dimensions of sleep and neurological assessment. His documented works address OSA, wakefulness electroencephalography, hematocrit and erythrocytosis, and the effects of psychotropic medication on sleep architecture. These subjects connect diagnostic assessment with clinically relevant sleep outcomes and provide a coherent basis for evaluating research activity in Medicine and Health Sciences. [1]

Keywords

Sleep medicine; obstructive sleep apnea; electroencephalography; polysomnography; sleep architecture; psychotropic medication; hematocrit; erythrocytosis; clinical research.

Introduction

Sleep disorders can involve respiratory, neurological, cardiovascular, and behavioral dimensions, making multidisciplinary clinical research particularly relevant. OSA is associated with measurable physiological changes and may require complementary diagnostic approaches. Research examining wakefulness EEG and hematological characteristics contributes to the broader clinical understanding of patients evaluated for sleep-related disorders. [2] [3]

Research Profile

The available record indicates a focused research trajectory around sleep-related clinical investigation. The profile combines observational clinical work with physiological measurement, including polysomnographic assessment and electroencephalographic evaluation. Bibliometric indicators reported for the researcher include three documents, 31 citations, and an h-index of 2. [1]

Research Contributions

The documented publications address complementary aspects of sleep-related medicine. One study examines the relationship between OSA and hematocrit or erythrocytosis, while another evaluates wakefulness EEG in OSA patients. A later article investigates class-specific and cumulative effects of psychotropic medication on sleep architecture using retrospective polysomnographic data. [2] [3] [4]

Publications

  • Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology, 2026. [4]
  • Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing, 2025. [2]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing, 2024. [3]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Research Square, 2024. [5]
  • O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco, 2023. [6]

Research Impact

The reported bibliometric record of 31 citations and an h-index of 2 provides a measurable indication of scholarly visibility. The publications also demonstrate continuity in sleep-related research across 2023–2026, with topics spanning intensive care, OSA assessment, hematological outcomes, and medication-associated changes in sleep architecture. [1]

Award Suitability

For the Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity in a defined medical research area. The combination of recent journal publications, sleep-medicine investigations, and identifiable bibliometric indicators offers an objective basis for consideration. Award assessment should additionally consider authorship roles, methodological quality, peer-review status, broader collaboration, and independent verification of bibliographic records.

Conclusion

Daniel Alfaiate’s documented research activity centers on clinically relevant questions in sleep and neurological assessment. His publications provide a coherent research profile involving OSA, EEG evaluation, hematological outcomes, and polysomnographic investigation. The available bibliometric and publication evidence supports consideration within an academic recognition framework, subject to standard verification procedures.

References

  1. Elsevier. (n.d.). Scopus author details: Daniel Alfaiate, Author ID 58158006300. Scopus.
    https://www.scopus.com/pages/authors/58158006300
  2. Springer Nature. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    DOI: 10.1007/s11325-025-03330-2
  3. Springer Nature. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    DOI: 10.1007/s11325-024-03116-y
  4. Elsevier. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    DOI: 10.1016/j.ejphar.2026.179292
  5. Research Square. (2024). Evaluation of wakefulness electroencephalogram in OSA patients.
    DOI: 10.21203/rs.3.rs-3831506/v1
  6. Instituto Politécnico de Castelo Branco. (2023). O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco.

Mehrdad Esmaeilipour | Biotechnology | Excellence in Innovation Award

Published on by Innovation Technologist

Mr. Mehrdad Esmaeilipour | Biotechnology | Excellence in Innovation Award

Parsa Pardazesh Booshehr Sanaat | Iran 

Mehrdad Esmaeilipour is a dedicated and results-driven electronic engineer with significant expertise in green technology, environmental sustainability, and smart system development. With a robust background in electronic circuit design, plasma systems, and digital health innovations, he plays a leading role in integrating engineering excellence with social impact. He currently contributes as a senior electronics engineer at a company specializing in air and water purification systems and also leads his own successful electronics and IT firm. His entrepreneurial mindset and technical expertise have led to multiple product innovations, including a smart bracelet for visually impaired individuals and several intelligent air purification systems. Additionally, he has made notable contributions to robotics through voluntary academic mentorship and team leadership.

Publication Profile 

Google Scholar

Educational Background 

He holds a bachelor’s and an associate degree in electronics engineering from Islamic Azad University. His educational background also includes foundational studies in electronics at a technical high school. His formal training has been further enhanced by certifications in cybersecurity, solar photovoltaic systems, HSE, robotics, and industrial safety.

Professional Experience 

Mehrdad has accumulated rich professional experience in both industrial and academic contexts. As a senior electronics engineer, he leads the design, development, and quality control of advanced electronic systems for environmental applications. In parallel, he serves as the CEO of an electronics and IT company where he manages cross-functional teams and has overseen the successful execution of security, networking, and software projects. His work also includes mentorship roles within university robotics teams, where he contributes to system design, sensor integration, and control strategies.

Research Interests 

His research focuses on environmental electronics, cold plasma technology, artificial intelligence in healthcare, robotic control systems, electronic data engineering, and smart wearable systems. He is particularly interested in developing sustainable technologies that address real-world challenges through a multidisciplinary approach.

Awards and Honors 

Mehrdad has received numerous international accolades for his engineering innovations and societal impact. These include the Tech Excellence Award, Best Wearable Sensing Technology Award, and Best Innovator Award, among others. He has also earned recognition from academic and professional organizations in both engineering and business domains.

Research Skills 

He possesses strong expertise in electronic circuit design, embedded systems, sensor integration, control systems (including PID and fuzzy logic), and smart system architecture. He is proficient in tools such as Altium Designer and Eagle, and he has demonstrated capability in both hardware and software integration for industrial and research applications. His skills are complemented by project management, analytical reasoning, and interdisciplinary collaboration.

Publications 

  1. Advancements in Cold Plasma Technology for Electronic and Surface Sterilization Applications
    Year: 2025

  2. Design, Construction and Performance Comparison of Fuzzy Logic Controller and PID Controller for Two-Wheel Balance Robot
    Year: 2025

  3. The Utilization of Artificial Intelligence Technologies in the Domain of Electronic Data Engineering
    Year: 2025

  4. Single Miller Compensation with Split Output and Current Amplifier Use in Three Stage Amplifiers to Drive Ultra Large Capacitive Loads
    Year: 2015

Conclusion 

Mehrdad Esmaeilipour exemplifies a forward-thinking engineer who merges technological innovation with a commitment to environmental and social betterment. His extensive practical experience, research output, and leadership across industry and academia reflect his capacity to contribute meaningfully to the advancement of electronic engineering and sustainability-driven technologies.

Monika Prakash | Medical Biotechnology | Best Researcher Award

Published on by Innovation Technologist

Dr. Monika Prakash | Medical Biotechnology | Best Researcher Award

Assistant Professor at Ramaiah Institute of Technology, India

Dr. Monika P is an accomplished academician and researcher with a focus on biotechnology, particularly in cell biology, nanobiotechnology, and wound healing. She is currently an Assistant Professor at the Department of Biotechnology, MS Ramaiah Institute of Technology (MSRIT), Bengaluru, where she has been teaching since November 2016. She has over 7 years of research experience and has contributed significantly to the development of novel therapeutic solutions for chronic wound healing, including research on fibroblasts, myofibroblasts, and phytocompounds.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Biotechnology, Visvesvaraya Technological University (VTU), Belagavi, 2023
  • M.Tech in Biotechnology, M.S. Ramaiah Institute of Technology (Autonomous Institute Affiliated to VTU), Bengaluru, 2014, CGPA: 9.43 (Second topper)
  • B.E. in Biotechnology, M.S. Ramaiah Institute of Technology, Bengaluru, 2011, CGPA: 8.8
  • P.U.C. (12th Standard), Maharani Lakshmi Ammanni College, Bengaluru, 2007, 83.5%
  • S.S.L.C. (10th Standard), Nirmala Rani High School, Bengaluru, 2005, 90.72%

Professional Experience 💼

  • Assistant Professor, Department of Biotechnology, MSRIT, Bengaluru, Nov 2016–Present
  • Over 8 years of teaching experience in various biotechnology-related courses
  • Guided multiple undergraduate and postgraduate student projects in fields like tissue engineering, nanobiotechnology, and chronic wound healing

Research Interests 🔬

  • Cell Biology & Cell Culture: Specialization in fibroblasts, myofibroblasts, and their role in wound healing.
  • Nanobiotechnology: Development of novel nanoformulations and scaffolds, especially for medical applications like chronic wound healing.
  • Phytocompounds: Investigating plant-based compounds for their therapeutic potential in wound healing, particularly for diabetic foot ulcers and burn wounds.
  • Chronic Wound Healing: Focus on developing low-cost, effective solutions for enhancing wound regeneration, especially for non-healing ulcers.

Awards and Honors🏆✨

  • Young Women Research Award (2025), Venus International Foundation
  • Certificate of Excellence for completing “Certified Peer Reviewer Course” from Elsevier Researcher Academy (2021)
  • Best Paper Presentation Award at the International Conference on Functional Materials, Energy, Environment, and Biomedical Applications (2022)
  • Best UG Project Award (2022) and other recognitions for mentoring top student projects
  • Best Technical Project Award from the Government of Karnataka for “Development of Nano-catechin for enhanced Bioavailability” (2014)
  • Publons Academy Graduate (2021), first from the institute

Conclusion🌟

Dr. Monika P is a dynamic academician and researcher with a passion for advancing biotechnology research, particularly in the realm of nanobiotechnology and chronic wound healing. Her strong academic background, extensive research experience, and dedication to student mentorship make her a significant contributor to the field of biotechnology. She has consistently earned recognition for her work and continues to foster innovation in her research and teaching. Through various collaborations and funded research projects, Dr. Monika P is paving the way for advancements in wound healing therapies and sustainable healthcare solutions.

Publications 📚

1. 📝 Monika, Prakash, Anushka Poola, Prithvi Prabhu, Samrat K.
“Key insights into recent advances and challenges in COVID‑19 Management”
Discover Public Health (2025) 22: 15.

2. 🧪 P. Monika, M. N. Chandraprabha, R. Hari Krishna, Vittal Maanya, C. Likhitha, N. Pooja.
“Development of targeted nanocapsules using pomegranate peel extract with enhanced bioavailability and anti-inflammatory activity for ulcerative colitis: In vitro studies”
Hybrid Advances, 2024.

3. 🔬 Prakash Monika, Hari Krishna Rajan, Chandraprabha MN, Sakshi Shetty, Tanushka Mukherjee, S. Girish Kumar.
“Recent Developments in Green Synthesis of Hydroxyapatite Nanocomposites: Relevance to Biomedical and Environmental Applications”
Green Chemistry Letters and Reviews, 2024 (IF- 6.6, Q1)

4. 💉 Prakash, M. N. Chandraprabha, Vivek Radhakrishnan, Prathik Somayaji, Leah Sabu.
“Therapeutic potential of silkworm sericin in wound healing applications.”
Wound Repair and Regeneration, 2024 (IF-3.8, Q1, H-index – 133).

5. 🧑‍🔬 Monika Prakash, M.N. Chandraprabha, R. Hari Krishna, Harini Satish, S. Girish Kumar.
“Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy.”
Applied Surface Science Advances. 2024, 19: 100540 (IF- 7.8, Q1).

6. 🔩 Gowda, Charishma C.; B., Lavanya; M. N., Chandra Prabha; Krishna, R. Hari; P., Monika.
“Bioceramics in Hip and Knee Implants.”
Journal of Mines, Metals & Fuels. 2023, 71 (3): 400-407. (Q4)

7. 🌿 Monika, Prakash, M. N. Chandraprabha, and K. N. Murthy.
“Catechin, epicatechin, curcumin, garlic, pomegranate peel and neem extracts of Indian origin showed enhanced anti-inflammatory potential in human primary acute and chronic wound derived fibroblasts by decreasing TGF-β and TNF-α expression.”
BMC Complementary Medicine and Therapies 23, no. 1 (2023): 1-16. (IF- 3.78, Q1)

8. 🧬 Monika, Prakash, M. N. Chandraprabha, KN Chidambara Murthy, P. Veena Waiker, and Annapoorni Rangarajan.
“Standardized ready-to-use laboratory protocol to isolate primary human wound associated fibroblasts from infected wound samples for clinical applications.”
Journal of Microbiological Methods (2023): 106712. (IF- 2.5, Q3)

9. 🧫 Monika, Prakash, M. N. Chandraprabha, and KN Chidambara Murthy.
“Gene expression studies in primary human acute and chronic wound fibroblasts treated with most popular wound healing phytoextracts.”
South African Journal of Botany 155 (2023): 205-213. (IF- 3.11, Q2).

10. 🔬 Krishna, R. Hari, M. N. Chandraprabha, Prakash Monika, Vishal Chaudhary, and C. Manjunatha.
“Biomolecule conjugated inorganic nanoparticles for biomedical applications: A review.”
Biotechnology and Genetic Engineering Reviews (2022): 1-42. (IF- 4.5, Q1).